Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.

Biotechnology

Acticor Biotech

Gilles Avenard

Antoine Lebel

Sandra Lourenço-Lopes

Alexandra Brochand

Véronia Safwat

Sophie Binay

Marion Galaup

Eric Cohen

Elie Toledano

Victoria Rutman

Yannick Plétan

Laurie Jullien

The leadership team at Acticor Biotech has a wealth of experience in early-stage portfolio management, investment analysis, project management, scientific research, and finance. They have also travelled extensively and have experience in regulatory affairs, quality control, and engineering.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Acticor Biotech

Board of Directors

CEO and Executive Team